Northstar sets shipping date for European expansion to almost
double its distribution.
HOLBROOK, N.Y., March 21, 2013 /PRNewswire/ -- Northstar
Global Business Services, Inc. Symbol (OTCPink: MDIN), today
announced it has already started manufacturing product for a
massive push into Europe with its
popular anti-snoring product, Snorenz. Once Snorenz is being sold
across Europe, the company has
plans to follow it with its other product lines shortly thereafter.
Manufacturing is already underway, and the company will be prepared
to ship approximately one million units starting August 1st to supply the initial non-US orders of
the product.
The company CEO, Nick Chieco
commented, "Obviously we are thrilled to have put this together and
working to coordinate with several distributors and overseas
manufacturers was challenging but rewarding." He went on to say, "I
know our shareholders and customers are anxious not only to see our
products on the shelves of retail stores near them, but to see the
exact sales numbers resulting from all of our hard work. Although
these transactions are extremely complex and take some time, we are
coming closer and closer to being able to deliver those two things.
When our current quarter's financials come out, I think everyone
will be impressed with our revenues and profit margins."
Outside the US, the retail price of a 2 ounce bottle of Snorenz
will be slightly higher, at about the equivalent of $14.00 USD, but the net profit to Northstar will
be about the same, and the company's research shows that due to
lack of competing products and current interest, the European
market should bear the price nicely. The company wants it known
that the Northstar is prepared to make its mark in the alternative
heathcare industry, not only nationally, but globally.
For more information about Northstar, Contact Jennifer at
1-877-571-4387 or Email: investors@northstarbb.com
About Northstar
Northstar Global Business Services is dedicated to producing the
best alternative healthcare products. The most popular products in
Northstar's arsenal are Snorenz©, a patented spray for snoring
relief and "Good Night's Sleep", an FDA approved sleep aid. Most of
the company's products use a unique spray delivery system, and have
received very positive consumer reviews all over the world, selling
millions upon millions of units from 1996 to the present.
DISCLAIMER
This Press Release may contain certain forward-looking statements
within the meaning of the Private Securities Litigation Reform Act
of 1995. The Company has tried, whenever possible, to identify
these forward-looking statements using words such as "anticipates,"
"believes," "estimates," "expects," "plans," "intends," "potential"
and similar expressions. These statements reflect the Company's
current beliefs and are based upon information currently available
to it. Accordingly, such forward-looking statements involve known
and unknown risks, uncertainties and other factors which could
cause the Company's actual results, performance or achievements to
differ materially from those expressed in or implied by such
statements. The Company undertakes no obligation to update or
advise in the event of any change, addition or alteration to the
information catered in this Press Release including such
forward-looking statements.
SOURCE Northstar Global Business Services, Inc.